Viana M - Search Results

1

A method of determining the dose of digoxin for heart failure in the modern era.

Bauman JL, DiDomenico RJ, Viana M, Fitch M. Bauman JL, et al. Among authors: viana m. Arch Intern Med. 2006 Dec 11-25;166(22):2539-45. doi: 10.1001/archinte.166.22.2539. Arch Intern Med. 2006. PMID: 17159022

2

Can the concentration of timolol or the frequency of its administration be reduced?

Letchinger SL, Frohlichstein D, Glieser DK, Higginbotham EJ, Wilensky JT, Viana MA, Zeimer R. Letchinger SL, et al. Among authors: viana ma. Ophthalmology. 1993 Aug;100(8):1259-62. doi: 10.1016/s0161-6420(93)31496-x. Ophthalmology. 1993. PMID: 8341511

3

Cytochrome P450 2C9 mediated metabolism in people with and without cancer.

Shord SS, Cavallari LH, Viana MA, Momary K, Neceskas J, Molokie RE, Deyo K, Patel SR. Shord SS, et al. Among authors: viana ma. Int J Clin Pharmacol Ther. 2008 Jul;46(7):365-74. doi: 10.5414/cpp46365. Int J Clin Pharmacol Ther. 2008. PMID: 18793590 Clinical Trial.

4

Genetic and clinical predictors of warfarin dose requirements in African Americans.

Cavallari LH, Langaee TY, Momary KM, Shapiro NL, Nutescu EA, Coty WA, Viana MA, Patel SR, Johnson JA. Cavallari LH, et al. Among authors: viana ma. Clin Pharmacol Ther. 2010 Apr;87(4):459-64. doi: 10.1038/clpt.2009.223. Epub 2010 Jan 13. Clin Pharmacol Ther. 2010. PMID: 20072124

5

Pharmacogenomics of warfarin dose requirements in Hispanics.

Cavallari LH, Momary KM, Patel SR, Shapiro NL, Nutescu E, Viana MA. Cavallari LH, et al. Among authors: viana ma. Blood Cells Mol Dis. 2011 Feb 15;46(2):147-50. doi: 10.1016/j.bcmd.2010.11.005. Epub 2010 Dec 24. Blood Cells Mol Dis. 2011. PMID: 21185752

6

Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.

Cavallari LH, Perera M, Wadelius M, Deloukas P, Taube G, Patel SR, Aquino-Michaels K, Viana MA, Shapiro NL, Nutescu EA. Cavallari LH, et al. Among authors: viana ma. Pharmacogenet Genomics. 2012 Feb;22(2):152-8. doi: 10.1097/FPC.0b013e32834f288f. Pharmacogenet Genomics. 2012. PMID: 22158446 Free PMC article.

7

Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients.

Cavallari LH, Butler C, Langaee TY, Wardak N, Patel SR, Viana MA, Shapiro NL, Nutescu EA. Cavallari LH, et al. Pharmacotherapy. 2011 Aug;31(8):785-92. doi: 10.1592/phco.31.8.785. Pharmacotherapy. 2011. PMID: 21923605

8

Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure.

Cavallari LH, Groo VL, Viana MA, Dai Y, Patel SR, Stamos TD. Cavallari LH, et al. Pharmacotherapy. 2010 Jan;30(1):1-9. doi: 10.1592/phco.30.1.1. Pharmacotherapy. 2010. PMID: 20030467

9

Association of beta-blocker dose with serum procollagen concentrations and cardiac response to spironolactone in patients with heart failure.

Cavallari LH, Momary KM, Groo VL, Viana MA, Camp JR, Stamos TD. Cavallari LH, et al. Among authors: viana ma. Pharmacotherapy. 2007 Jun;27(6):801-12. doi: 10.1592/phco.27.6.801. Pharmacotherapy. 2007. PMID: 17542763 Clinical Trial.

10

Racial differences in potassium response to spironolactone in heart failure.

Cavallari LH, Groo VL, Momary KM, Fontana D, Viana MA, Vaitkus P. Cavallari LH, et al. Among authors: viana ma. Congest Heart Fail. 2006 Jul-Aug;12(4):200-5. doi: 10.1111/j.1527-5299.2006.05502.x. Congest Heart Fail. 2006. PMID: 16894278 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results